HealthTech startup ecosystem
European healthtech startups are transforming care delivery, diagnostics, and drug discovery. Strong public health systems create natural testing grounds, while regulatory clarity through CE marking and the MDR framework gives European companies a path to scale. We track 207 organisations in this sector across 6+ countries.
Showing 21–40 of 207 HealthTech
Countries in this sector
Sectors alongside this one
HealthTech results
-
Aqemia
Aqemia is a Paris-based pharmatech company building an AI-driven drug discovery platform that combines quantum-inspired physics and machine learning to generate and prioritise novel drug candidates at scale. Founded in 2019 by quantum physics researcher Maximilien Levesque and former BCG consultant Emmanuelle Martiano, the company aims to design new molecules faster and cheaper than traditional methods. It raised a 60M euro Series A and later a $38M round led by Cathay Innovation in December 2024, bringing total funding past $100 million as it moves toward clinical trials and global expansion, including a London office.
-
AstraNICE
Develops a patented near-infrared fluorescent coating (NICE) for surgical instruments, letting surgeons visualise tools inside the body during minimally invasive procedures. Spun out of Strasbourg's Laboratory of Bioimaging and Pathologies.
-
Atrandi Biosciences
Develops Semi-Permeable Capsule and droplet microfluidics partitioning technology enabling multi-step, multi-omic single-cell analysis workflows for research and high-throughput screening.
-
BIO-Europe Spring 2026
Life sciences partnering conference in Lisbon built around structured 1:1 meetings between biotech startups, pharma companies, and investors. Registration costs about EUR 2800+. Covers drug discovery, clinical development, and licensing. Essential for biotech startups seeking licensing deals, co-development partnerships, and Series A+ funding from specialized life-science investors.
-
BioFIT 2026
Europe's leading partnering event for early-stage life-sciences innovation and technology transfer, in its 15th edition at Parc Chanot in Marseille. Built around one-on-one partnering meetings, it is ideal for biotech and medtech founders seeking licensing deals, academic collaborations, and early investors.
-
BioInnovation Institute (BII)
BioInnovation Institute is a life science incubator backed by the Novo Nordisk Foundation that helps researchers and founders turn biotech and health innovations into venture ready companies. Based in Copenhagen, BII provides lab space, grant funding, expert business support, and access to investors for projects in therapeutics, diagnostics, and industrial biotech. It runs programs for both idea stage research and early startups, de risking science heavy ventures before they seek larger capital. BII is a central node in the Danish life science startup pipeline.
-
BIOSPAIN 2026
One of Europe's largest biotech partnering events, in its 13th edition and run by industry association AseBio, known for its high volume of one-to-one investor and company meetings. Essential for biotech and life-sciences founders raising capital or seeking pharma and research partners.
-
Buildit
Buildit is a Riga-based hardware and IoT accelerator-VC hybrid founded in 2014, operating as the first accelerator in the Baltics and Nordics focused on physical-device startups. It runs cohort programmes and provides pre-seed funding up to €250k for Latvia-incorporated startups, with seed follow-on up to €1.5M for Baltic and Nordic companies. The firm has made over 120 investments and manages the Buildit Latvia Pre-Seed Fund (2022 vintage). Portfolio companies span energy, health tech, smart living, and robotics, including Aerones.
-
Cambridge Tech Week 2026
Built around the Cambridge deep-tech cluster, with a 2026 theme of how deep tech changes the world. It features an Innovation Alley exhibition for deeptech startups and scaleups, plus sessions on scaling, regulation, and access to capital — high value for science-led founders seeking investors and corporate partners.
-
Cardiomatics
Cardiomatics develops cloud-based AI software that automates reading and interpretation of electrocardiograms (ECG), detecting ~20 heart abnormalities and generating diagnostic reports in minutes. It received European medical-device certification in 2018 and has analysed millions of hours of ECG signals for 700+ customers across 10+ countries.
-
Clinical Trials Information Network
Clinical Trials Information Network, founded in 2023 and headquartered in Warsaw, operates ClinicalTrials.eu, a patient-focused platform that makes clinical trial information across Europe more accessible. It aggregates publicly available data from international trial registries, academic centres, national regulators and commercial sponsors, letting users search trials by disease, drug name or location and access structured patient materials.
-
contextflow
contextflow is a Vienna-based medical AI company that builds computer-aided diagnostic tools for chest CT analysis, including its ADVANCE Chest CT suite for detecting and quantifying lung cancer, ILD and COPD, plus products for PACS integration and pharma use. It was founded in July 2016 out of the Medical University of Vienna and the EU-funded Khresmoi research project, with support from TU Wien. The company has been recognised as Best Healthtech Startup Austria by the Central European Startup Awards and has received grants and investment from the European Innovation Council.
-
Corti
Corti is a Copenhagen-based AI company founded in 2016 that initially gained recognition for building real-time AI assistants for emergency call centers, helping dispatchers detect cardiac arrests and other critical conditions during 112/911 calls. The company has since expanded into broader healthcare AI infrastructure, providing clinical documentation, medical coding, and workflow automation tools for hospitals and health systems. Corti's models are trained on millions of patient interactions and support clinicians in making faster, more accurate decisions. The company is one of Denmark's most prominent healthcare AI startups.
-
CurifyLabs
CurifyLabs is a Helsinki-based HealthTech company automating the production of personalised medicines. Its Compounding System Solution combines proprietary software, GMP-manufactured excipient bases, and 3D-printing hardware (including the PharmaPrinter Aurum) to let pharmacies compound and dispense custom-dosed medications up to nine times faster than manual methods. Founded in 2021 by Charlotta Topelius and Niklas Sandler — a professor of pharmaceutical technology at Åbo Akademi University with over a decade researching automated compounding — the company's technology is already in use across pharmacies in 21 U.S. states and multiple European countries. In July 2026, CurifyLabs closed a $14 million Series A, co-led by Sandwater and HealthCap with participation from Tesi (Finnish Industry Investment Ltd.) and existing investor Lifeline Ventures, to expand its compounding platform.
-
Dawn Health
Dawn Health develops regulated software-as-a-medical-device products with pharmaceutical and life-science partners. The company builds digital therapeutics and companion applications for adherence, remote monitoring, and real-world clinical data capture in regulated settings.
-
Debbie Rennick
General Partner at ACT Venture Capital, where she has built her career since the 1990s. A chartered accountant and former KPMG corporate-finance professional, she invests across software, health tech and deep tech and works closely with founders on growth and exits.
-
Deciphex
AI-powered digital pathology company pairing artificial intelligence with a global network of expert pathologists. Its Diagnexia (clinical) and Patholytix (preclinical) platforms speed diagnosis and ease the pathologist shortage. Founded 2017.
-
Delphine Groll
Co-founder and COO of Nabla, leading operations and partnerships for the clinical-documentation AI company used by thousands of practitioners.
-
Delta Partners
Founded in 1994, Delta Partners is one of Ireland's longest-running venture capital firms, investing EUR 0.5-3M at seed and Series A in enterprise software and consumer technology across Ireland and the UK. The firm manages over EUR 300M across multiple funds backed by Enterprise Ireland and private LPs. Delta has backed 90+ companies including Movidius (acquired by Intel), CurrencyFair, and Luzern. The team focuses on capital-efficient B2B and consumer startups with international scaling potential.
-
Distalmotion
Distalmotion develops Dexter, a hybrid robotic surgery platform intended to make robotic-assisted minimally invasive procedures more accessible to a broader hospital base. The system allows surgeons to move between robotic and laparoscopic workflows during operations to improve flexibility and operating-room integration.
